- Home
- ABM vs GPCR Comparison
ABM vs GPCR Comparison
Compare ABM & GPCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Company Overview
Basic Information| Metric | ABM | GPCR |
|---|---|---|
| Founded | 1909 | 2016 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Diversified Commercial Services | |
| Sector | Finance | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.7B | 2.8B |
| IPO Year | 1994 | 2023 |
Fundamental Metrics
Financial Performance| Metric | ABM | GPCR |
|---|---|---|
| Price | $48.56 | $49.12 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 5 | 12 |
| Target Price | $47.80 | ★ $103.17 |
| AVG Volume (30 Days) | 398.7K | ★ 660.5K |
| Earning Date | 06-05-2026 | 05-08-2026 |
| Dividend Yield | ★ 2.92% | N/A |
| EPS Growth | ★ 102.34 | N/A |
| EPS | ★ 1.37 | N/A |
| Revenue | ★ $8,745,900,000.00 | N/A |
| Revenue This Year | $5.97 | N/A |
| Revenue Next Year | $3.45 | N/A |
| P/E Ratio | $34.83 | ★ N/A |
| Revenue Growth | ★ 4.62 | N/A |
| 52 Week Low | $36.96 | $15.80 |
| 52 Week High | $50.12 | $94.90 |
Technical Indicators
Market Signals| Indicator | ABM | GPCR |
|---|---|---|
| Relative Strength Index (RSI) | 71.13 | 51.85 |
| Support Level | $43.04 | $43.76 |
| Resistance Level | $50.12 | $57.15 |
| Average True Range (ATR) | 1.05 | 2.71 |
| MACD | 0.12 | -0.55 |
| Stochastic Oscillator | 93.85 | 42.37 |
Price Performance
Historical ComparisonAbout ABM ABM Industries Incorporated
ABM Industries Inc is a provider of integrated facility solutions. It offers its solutions through five segments: Business and Industry, Manufacturing and Distribution, Education, Aviation and Technical solutions. The company derives the majority of its revenue from the business and industry segment, which encompasses janitorial, facilities engineering, and parking services for commercial real estate properties and sports and entertainment venues, hospitals, as well as vehicle maintenance and other services to rental car providers. The company mainly operates in the United States of America.
About GPCR Structure Therapeutics Inc.
Structure Therapeutics Inc is a clinical-stage biopharmaceutical company developing novel oral small-molecule therapeutics to treat a wide range of chronic diseases with unmet medical needs. Its differentiated technology platform leverages both structure-based drug discovery and expertise in computational chemistry to discover and develop small molecule therapeutics against G-protein coupled receptors (GPCRs). The group operates and manages its business as one reportable and operating segment, which is the business of research and development of medicines that target chronic diseases with unmet medical needs.